1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)
  4. Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/217320
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIbernón, Meritxell-
dc.contributor.authorNavarro, Maru-
dc.contributor.authorGoma, Montserrat-
dc.contributor.authorTango, Ariel-
dc.contributor.authorRap, Oana-
dc.contributor.authorCabrera, Cristina-
dc.contributor.authorSánchez, Ana-
dc.contributor.authorRodriguez, Neus-
dc.contributor.authorRuiz, Pilar-
dc.date.accessioned2025-01-08T12:30:42Z-
dc.date.available2025-01-08T12:30:42Z-
dc.date.issued2024-05-01-
dc.identifier.issn1460-2385-
dc.identifier.urihttps://hdl.handle.net/2445/217320-
dc.descriptionComunicació/presentació a: 61st ERA Congress, The European Renal Association, Estocolm, 23-26 maig 2024-
dc.description.abstractDiabetes Mellitus type 2 (DM2) leads to chronic kidney disease in a 30-40% of diabetic patients and it is the major cause of end stage renal disease (ESRD). The clinical course of diabetic kidney disease is very heterogeneous and there is a lack of agreement between clinical parameters and renal histology. Besides, lesions of non-diabetic kidney disease (NDRD) can coexist with lesions of diabetic nephropathy (DN) in two-thirds of kidney biopsies in patients with diabetes.-
dc.format.extent4 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherOxford University Press (OUP)-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1093/ndt/gfae069.1086-
dc.relation.ispartofNephrology Dialysis Transplantation, 2024, vol. 39, sup. 1, p. i1768-i1771-
dc.relation.urihttps://doi.org/10.1093/ndt/gfae069.1086-
dc.rights(c) Ibernón, Meritxell et al., 2024-
dc.sourceComunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationNefropaties diabètiques-
dc.subject.classificationDiabetis no-insulinodependent-
dc.subject.classificationMalalties del ronyó-
dc.subject.otherDiabetic nephropathies-
dc.subject.otherNon-insulin-dependent diabetes-
dc.subject.otherKidney diseases-
dc.titleThe role of sodium-glucose cotransporter 2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type 2 patients-
dc.typeinfo:eu-repo/semantics/conferenceObject-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.date.updated2024-12-13T10:02:40Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
gfae069-1086-1626.pdf759.41 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.